364 related articles for article (PubMed ID: 25677450)
21. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
22. Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.
Liu PY; Hsieh TY; Liu ST; Chang YL; Lin WS; Wang WM; Huang SM
Exp Cell Res; 2011 Dec; 317(20):2925-37. PubMed ID: 22001409
[TBL] [Abstract][Full Text] [Related]
23. Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein.
Kasahara H; Usheva A; Ueyama T; Aoki H; Horikoshi N; Izumo S
J Biol Chem; 2001 Feb; 276(7):4570-80. PubMed ID: 11042197
[TBL] [Abstract][Full Text] [Related]
24. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.
Pierantoni GM; Rinaldo C; Esposito F; Mottolese M; Soddu S; Fusco A
Cell Death Differ; 2006 Sep; 13(9):1554-63. PubMed ID: 16341121
[TBL] [Abstract][Full Text] [Related]
25. Combinatorial interactions regulating cardiac transcription.
Durocher D; Nemer M
Dev Genet; 1998; 22(3):250-62. PubMed ID: 9621432
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects.
Kodo K; Nishizawa T; Furutani M; Arai S; Ishihara K; Oda M; Makino S; Fukuda K; Takahashi T; Matsuoka R; Nakanishi T; Yamagishi H
Circ J; 2012; 76(7):1703-11. PubMed ID: 22498567
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
Lohrum M; Scheidtmann KH
Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
[TBL] [Abstract][Full Text] [Related]
28. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
29. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies.
Kasahara H; Benson DW
Cardiovasc Res; 2004 Oct; 64(1):40-51. PubMed ID: 15364612
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of natriuretic peptides in the ventricle of Csx/Nkx2-5 transgenic mice.
Takimoto E; Mizuno T; Terasaki F; Shimoyama M; Honda H; Shiojima I; Hiroi Y; Oka T; Hayashi D; Hirai H; Kudoh S; Toko H; Kawamura K; Nagai R; Yazaki Y; Komuro I
Biochem Biophys Res Commun; 2000 Apr; 270(3):1074-9. PubMed ID: 10772952
[TBL] [Abstract][Full Text] [Related]
31. PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context.
Valentino T; Palmieri D; Vitiello M; Pierantoni GM; Fusco A; Fedele M
Cell Death Dis; 2013 Dec; 4(12):e963. PubMed ID: 24336083
[TBL] [Abstract][Full Text] [Related]
32. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression.
Lee Y; Shioi T; Kasahara H; Jobe SM; Wiese RJ; Markham BE; Izumo S
Mol Cell Biol; 1998 Jun; 18(6):3120-9. PubMed ID: 9584153
[TBL] [Abstract][Full Text] [Related]
33. Synergistic activation of transcription by CBP and p53.
Gu W; Shi XL; Roeder RG
Nature; 1997 Jun; 387(6635):819-23. PubMed ID: 9194564
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
35. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
36. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism.
Dai YS; Cserjesi P; Markham BE; Molkentin JD
J Biol Chem; 2002 Jul; 277(27):24390-8. PubMed ID: 11994297
[TBL] [Abstract][Full Text] [Related]
37. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
38. ZBP-89 promotes growth arrest through stabilization of p53.
Bai L; Merchant JL
Mol Cell Biol; 2001 Jul; 21(14):4670-83. PubMed ID: 11416144
[TBL] [Abstract][Full Text] [Related]
39. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
40. NFAT directly regulates Nkx2-5 transcription during cardiac cell differentiation.
Chen Y; Cao X
Biol Cell; 2009 Jun; 101(6):335-49. PubMed ID: 18828760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
